These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 27242375

  • 1. In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.
    Pompilio A, Crocetta V, Verginelli F, Di Bonaventura G.
    FEMS Microbiol Lett; 2016 Jul; 363(14):. PubMed ID: 27242375
    [Abstract] [Full Text] [Related]

  • 2. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY, Lee K, Chung HS, Hong SG, Suh Y, Chong Y.
    Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
    [Abstract] [Full Text] [Related]

  • 3. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
    Wu K, Yau YC, Matukas L, Waters V.
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1546-8. PubMed ID: 23295930
    [Abstract] [Full Text] [Related]

  • 4. Effect of antimicrobials on Stenotrophomonas maltophilia biofilm.
    Santos Carvalhais BE, Souza E Silva C, Dos Santos KV.
    Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
    [Abstract] [Full Text] [Related]

  • 5. Stenotrophomonas maltophilia Differential Gene Expression in Synthetic Cystic Fibrosis Sputum Reveals Shared and Cystic Fibrosis Strain-Specific Responses to the Sputum Environment.
    Willsey GG, Eckstrom K, LaBauve AE, Hinkel LA, Schutz K, Meagher RJ, LiPuma JJ, Wargo MJ.
    J Bacteriol; 2019 Aug 01; 201(15):. PubMed ID: 31109991
    [Abstract] [Full Text] [Related]

  • 6. Genotypic and Phenotypic Characterization of Stenotrophomonas maltophilia Strains from a Pediatric Tertiary Care Hospital in Serbia.
    Madi H, Lukić J, Vasiljević Z, Biočanin M, Kojić M, Jovčić B, Lozo J.
    PLoS One; 2016 Aug 01; 11(10):e0165660. PubMed ID: 27798695
    [Abstract] [Full Text] [Related]

  • 7. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
    Biočanin M, Madi H, Vasiljević Z, Kojić M, Jovčić B, Lozo J.
    Pol J Microbiol; 2017 Dec 04; 66(4):433-438. PubMed ID: 29319523
    [Abstract] [Full Text] [Related]

  • 8. Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation.
    Liaw SJ, Lee YL, Hsueh PR.
    Int J Antimicrob Agents; 2010 Feb 04; 35(2):126-30. PubMed ID: 19926255
    [Abstract] [Full Text] [Related]

  • 9. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
    Pompilio A, Crocetta V, Scocchi M, Pomponio S, Di Vincenzo V, Mardirossian M, Gherardi G, Fiscarelli E, Dicuonzo G, Gennaro R, Di Bonaventura G.
    BMC Microbiol; 2012 Jul 23; 12():145. PubMed ID: 22823964
    [Abstract] [Full Text] [Related]

  • 10. Biofilm Eradication of Stenotrophomonas maltophilia by Levofloxacin and Trimethoprim-Sulfamethoxazole.
    Río-Chacón JMD, Rojas-Larios F, Bocanegra-Ibarias P, Salas-Treviño D, Espinoza-Gómez F, Camacho-Ortiz A, Flores-Treviño S.
    Jpn J Infect Dis; 2024 Jul 23; 77(4):213-219. PubMed ID: 38296539
    [Abstract] [Full Text] [Related]

  • 11. Cystic Fibrosis-Associated Stenotrophomonas maltophilia Strain-Specific Adaptations and Responses to pH.
    Gallagher T, Phan J, Oliver A, Chase AB, England WE, Wandro S, Hendrickson C, Riedel SF, Whiteson K.
    J Bacteriol; 2019 Apr 01; 201(7):. PubMed ID: 30642989
    [Abstract] [Full Text] [Related]

  • 12. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
    Ratjen A, Yau Y, Wettlaufer J, Matukas L, Zlosnik JE, Speert DP, LiPuma JJ, Tullis E, Waters V.
    Antimicrob Agents Chemother; 2015 Jan 01; 59(1):711-3. PubMed ID: 25348526
    [Abstract] [Full Text] [Related]

  • 13. Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates.
    Montoya-Hinojosa EI, Villarreal-Treviño L, Bocanegra-Ibarias P, Camacho-Ortiz A, Flores-Treviño S.
    Microb Drug Resist; 2024 Sep 01; 30(9):354-362. PubMed ID: 39029506
    [Abstract] [Full Text] [Related]

  • 14. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
    Passerini de Rossi B, García C, Calenda M, Vay C, Franco M.
    Int J Antimicrob Agents; 2009 Sep 01; 34(3):260-4. PubMed ID: 19362452
    [Abstract] [Full Text] [Related]

  • 15. Stenotrophomonas maltophilia phenotypic and genotypic features through 4-year cystic fibrosis lung colonization.
    Alcaraz E, Centrón D, Camicia G, Quiroga MP, Di Conza J, Passerini de Rossi B.
    J Med Microbiol; 2021 Jan 01; 70(1):. PubMed ID: 33258754
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.
    Pollini S, Di Pilato V, Landini G, Di Maggio T, Cannatelli A, Sottotetti S, Cariani L, Aliberti S, Blasi F, Sergio F, Rossolini GM, Pallecchi L.
    PLoS One; 2018 Jan 01; 13(10):e0203941. PubMed ID: 30273348
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital.
    Pien CJ, Kuo HY, Chang SW, Chen PR, Yeh HW, Liu CC, Liou ML.
    J Microbiol Immunol Infect; 2015 Jun 01; 48(3):291-5. PubMed ID: 24239064
    [Abstract] [Full Text] [Related]

  • 18. Phenotypic and Transcriptomic Analyses of Seven Clinical Stenotrophomonas maltophilia Isolates Identify a Small Set of Shared and Commonly Regulated Genes Involved in the Biofilm Lifestyle.
    Alio I, Gudzuhn M, Pérez García P, Danso D, Schoelmerich MC, Mamat U, Schaible UE, Steinmann J, Yero D, Gibert I, Kohl TA, Niemann S, Gröschel MI, Haerdter J, Hackl T, Vollstedt C, Bömeke M, Egelkamp R, Daniel R, Poehlein A, Streit WR.
    Appl Environ Microbiol; 2020 Nov 24; 86(24):. PubMed ID: 33097507
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.
    Pompilio A, Pomponio S, Crocetta V, Gherardi G, Verginelli F, Fiscarelli E, Dicuonzo G, Savini V, D'Antonio D, Di Bonaventura G.
    BMC Microbiol; 2011 Jul 05; 11():159. PubMed ID: 21729271
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions.
    Pompilio A, Crocetta V, Pomponio S, Fiscarelli E, Di Bonaventura G.
    Diagn Microbiol Infect Dis; 2015 Aug 05; 82(4):318-25. PubMed ID: 26004353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.